Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. SGS North America Inc.
483
•SGS North America Inc.•March 20, 2026

SGS North America Inc. – FDA 483, Mar 20, 2026

Record Details

From March 17 to March 20, 2026, the FDA conducted an inspection of SGS North America Inc., a contract laboratory located in Lincolnshire, Illinois. The resulting FDA Form 483 outlines a significant violation regarding the firm’s laboratory control systems. Specifically, the investigator observed that the laboratory failed to establish scientifically sound procedures to ensure drug products and raw materials conform to standards of identity, quality, and purity. The primary issue identified was the firm’s reliance on a supplier’s Certificate of Analysis (COA) for reference standards without performing independent verification testing. This failure to confirm the identity and suitability of reference standards occurred during critical operations, including method transfer studies and the release testing of various drug batches for assay, impurities, and dissolution. These standards are foundational to ensuring the accuracy of analytical results. The inspection was performed under the regulatory framework of Section 704(b) of the Federal Food, Drug, and Cosmetic (FD&C) Act. While the observations do not constitute a final determination of non-compliance, the company is expected to respond to the FDA. Required actions include establishing robust verification protocols for all incoming reference standards, updating Standard Operating Procedures, and providing evidence of corrective measures to ensure future adherence to quality standards.

Company
SGS North America Inc.
Inspection date
March 20, 2026
Product type
drugs
Office
Chicago District Office
People
  • Gabriel Bermudez-Picart (investigator)
  • Michele L. Glendenning
View Company Profile

ID · eaa78b6f-c64f-4dc6-9e78-12e6c071b4f9

Violation Codes2
FD&C Act 704(b)21 U.S.C. 374(b)

Full citation text and observation details available on the Dashboard.

Other documents for SGS North America Inc.
  • 483 - 2023-01-10January 10, 2023
  • EIR - 2019-04-24April 24, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SGS North America Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.